Search research articles
Contact Us
Filters
Showing results (471-480 of 527) with videos related to
Page
of 53
Sort By:
Journal of Gastroenterology and Hepatology
|
March 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Alimentary Pharmacology & Therapeutics
|
January 4, 2024
Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response
Jung Eun Park, Vy H Nguyen, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences
|
October 27, 2023
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Hepatology International
|
August 8, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, et al.
American Journal of Cancer Research
|
August 15, 2022
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, et al.
Alimentary Pharmacology & Therapeutics
|
May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study
Rui Huang, Ai-Thien Do, Hidenori Toyoda, et al.
The American Journal of Gastroenterology
|
March 30, 2020
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Chung-Feng Huang, Hsueh-Chou Lai, Chi-Yi Chen, et al.
Scientific Reports
|
March 28, 2020
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.
Hepatology International
|
November 25, 2021
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study
Lung-Yi Mak, Joseph Hoang, Dae Won Jun, et al.
Journal of Gastroenterology and Hepatology
|
May 8, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, et al.
Page
of 53
Search research articles
Search
Showing results (471-480 of 527) with videos related to
Sort By:
Page
of 53
Journal of Gastroenterology and Hepatology
|
March 13, 2024
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Alimentary Pharmacology & Therapeutics
|
January 4, 2024
Racial and ethnic disparities in untreated patients with hepatitis C virus-related hepatocellular carcinoma but not in those with sustained virologic response
Jung Eun Park, Vy H Nguyen, Pei-Chien Tsai, et al.
The Kaohsiung Journal of Medical Sciences
|
October 27, 2023
Pretreatment gamma-glutamyl transferase predicts mortality in patients with chronic hepatitis B treated with nucleotide/nucleoside analogs
Tyng-Yuan Jang, Po-Cheng Liang, Dae Won Jun, et al.
Hepatology International
|
August 8, 2021
Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Ming-Lun Yeh, Chao-Hung Hung, Kuo-Chih Tseng, et al.
American Journal of Cancer Research
|
August 15, 2022
Risk stratification of hepatocellular carcinoma incidence using a fibrosis-4-based prediction model in patients with chronic hepatitis C receiving antiviral therapy: a nationwide real-world Taiwanese cohort study
Hung-Wei Wang, Pei-Chein Tsai, Chi-Yi Chen, et al.
Alimentary Pharmacology & Therapeutics
|
May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B Study
Rui Huang, Ai-Thien Do, Hidenori Toyoda, et al.
The American Journal of Gastroenterology
|
March 30, 2020
Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)
Chung-Feng Huang, Hsueh-Chou Lai, Chi-Yi Chen, et al.
Scientific Reports
|
March 28, 2020
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis
Wei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.
Hepatology International
|
November 25, 2021
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B study
Lung-Yi Mak, Joseph Hoang, Dae Won Jun, et al.
Journal of Gastroenterology and Hepatology
|
May 8, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)
Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, et al.
Page
of 53